Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
life sciences
national blog main
new york blog main
new york top stories
type 2 diabetes
6
×
boston blog main
europe blog main
europe top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
indiana blog main
indiana top stories
investing
national
national top stories
startups
alzheimer's disease
autoimmune diseases
cancer immunotherapy
detroit blog main
detroit top stories
merck
parkinson's disease
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
What
bio
roundup
amid
bombast
cancer
caught
companies
coronavirus
days
debate
develop
discussion
efforts
life
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
science
street
tuesday’s
vaccine
viewers
wall
week
approval
arrival
babies
bid
biotech
birth
black
boehringer
born
breastfeed
continue
debut
Language
unset
Current search:
" type 2 diabetes "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome